Determinants of vascular dementia in the Cardiovascular Health Cognition Study

Neurology

Volumn 64, Issue 9, 2005, Pages 1548-1552

  Kuller, L H ^a,b   Lopez, O L ^b   Jagust, W J ^c   Becker, J T ^b   DeKosky, S T ^b   Lyketsos, C ^d   Kawas, C ^e   Breitner, J C S ^f   Fitzpatrick, A ^f   Dulberg, C ^f  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN INFARCTION; BRAIN VENTRICLE; CAUCASIAN; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DEMENTIA; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEGRO; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; STROKE; WHITE MATTER;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; BRAIN; CARDIOVASCULAR DISEASES; CEREBRAL ARTERIES; CEREBRAL INFARCTION; COHORT STUDIES; COMORBIDITY; CONTINENTAL POPULATION GROUPS; DEMENTIA, VASCULAR; FEMALE; HUMANS; LATERAL VENTRICLES; MAGNETIC RESONANCE IMAGING; MALE; NERVE FIBERS, MYELINATED; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; SEX FACTORS;

EID: 20944445212     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000160115.55756.DE     Document Type: Article

References (26)

1. Lopez OL, Kuller LH, Fitzpatrick A, Ives D, Becker JT, Beauchamp N. Evaluation of dementia in the Cardiovascular Health Cognition Study. Neuroepidemiology 2003;22:1-12.
2. Kuller LH, Lopez OL, Newman A, et al. Risk factors for dementia in the Cardiovascular Health Cognition Study. Neuroepidemiology 2003;22:13-22.
3. Pohjasvaara T, Mantyla R, Ylikoski R, Kaste M, Erkinjuntti T. Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of VaD. Stroke 2000;31:2952-2957.
4. Bernick C, Kuller L, Dulberg C, et al., for the Cardiovascular Health Study. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology 2001;57:1222-1229.
5. Kuller LH, Longstreth WT Jr, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ Jr, for the Cardiovascular Health Study Collaborative Research Group. White matter hyperintensity on cranial magnetic resonance imaging. A predictor of stroke. Stroke 2004;35:1821-1825.
6. Manolio T, Burke GL, O'Leary DH, et al., for the CHS Collaborative Research Group. Relationship of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999;19:356-365.
7. Johnston SC, O'Meara ES, Manolio TA, Lefkowitz D, O'Leary DH, Goldstein S, Carlson MC, Fried LP, Longstreth WT Jr. Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med 2004;140:237-247.
8. Chui HC, Victoroff JIB, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic VaD proposed by the state of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480.
9. McKhann G, Drachman DA, Folstein MF, Katzman R, Price DL, Stadlan E. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
10. Roman GC, Tatemichi TK, Erkinjuntti T, et al. VaD: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
11. Bryan RN, Manolio TA, Schertz LD, et al. A method for using MR to evaluate effects of cardiovascular disease on the brain: the Cardiovascular Health Study. Am J Neuroradiol 1994;15:1625-1633.
12. Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR. Lacunar infarcts defined by magnetic resonance imaging of 3600 elderly people: the Cardiovascular Health Study. Arch Neurol 1998;55:1217-1225.
13. Longstreth WT Jr, Dulberg C, Manolio TA, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2002;33:2376-2382.
14. Yue NC, Arnold AM, Longstreth WT Jr., et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the Cardiovascular Health Study. Radiology 1997;2002:33-39.
15. Norusis MJ. SPSS for Windows, Advanced Statistics, Release 6.0. Chicago: SPSS, Inc., 1993.
16. Breteler MM, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994;44:1246-1252.
17. Roher AE, Esh C, Kokjohn TA, et al. Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol 2003;23:2055-2062.
18. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 2004;62:1148-1155.
19. Kovari E, Gold G, Herrmann FR, et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 2004;35:410-414.
20. Schmidt W-P, Roesler A, Kretzschmar K, Ladwig K-H, Junker R, Berger K. Functional and cognitive consequences of silent stroke discovered using brain magnetic resonance imaging in an elderly population. J Am Geriatr Soc 2004;52:1045-1050.
21. White L, Petrovitch H, Hardman J, Nelson J, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. In: de la Torre JC, Kalaria R, Nakajima K, Nagata K, eds. Alzheimer's disease. Vascular etiology and pathology. Ann NY Acad Sci 2002;977:9-23.
22. Greenberg SM, Gurol E, Rosand J, Smith EE. Amyloid angiopathy-related vascular cognitive impairment. Stroke 35:2616-2619, 2004.
23. Fox MC, Schott JM. Imaging cerebral atrophy: normal ageing to Alzheimer's disease. Lancet 2004;363:392-394.
24. Goulding JMR, Signorini DF, Chatterjee S, et al. Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. J Neurol Neurosurg Psychiatry 1999;67:654-657.
25. Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke 2004;35:2620-2622.
26. Erkinjuntti T, Roman G, Gauthier S, Feldman H, Rockwood K. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 2004;35:1010-1017.